Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Apr, 10 2026
Apr, 26 2025
Sep, 29 2025
Oct, 21 2025
Dec, 10 2025